BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: A single center comparative analysis of efficacy and toxicity-Reference-Cited by-同舟云学术

BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: A single center comparative analysis of efficacy and toxicity

Published:2011-02 Issue:2 Volume:35 Page:183-187
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Kim Jeong Eun,Lee Dae Ho,Yoo Changhoon,Kim Shin,Kim Sang-We,Lee Jung-Shin,Park Chan Jeong,Huh Jooryung,Suh Cheolwon

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference30 articles.

1. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma;Gianni;N Engl J Med,1997

2. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d’Etude des Lymphomes de l’Adulte;Haioun;J Clin Oncol,1997

3. Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens;Salar;Bone Marrow Transplant,2001

4. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support;Milpied;N Engl J Med,2004

5. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project;N Engl J Med,1993

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Toxicity and Efficacy of Four Different Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Patients With Lymphoma: Impact of Drug Shortages in a Resource-Constrained Country;Transplantation and Cellular Therapy;2024-08

2. Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study;Asia-Pacific Journal of Clinical Oncology;2022-05-22

3. Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma;Hematology;2022-04-12

4. BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas;Leukemia Research;2021-11

5. Comparison of mitoxantrone–melphalan and BEAM conditioning regimens in patients with lymphoma;Hematology/Oncology and Stem Cell Therapy;2021-04